Coraviemedical
2 known investors
CoraVie Medical is an early-stage company developing an implantable, ultrasound-based device for continuous, long-term blood pressure monitoring in people with hypertension. The system provides automatic measurement without cuffs or manual logging, aimed at giving physicians more reliable data for earlier intervention.
Founders & leadership
AG
Aimee GarzaFounder and CEO
PA
Paul A. SobotkaChief Medical Officer
ES
Erik ScottChief Architect
SS
Steve SchwisterVP Program Management
Investors · 2
Competitors · 5
by search overlap
Aviary Health5 shared keywordsAviary Health provides virtual and hybrid clinical programs — including cardiac rehabilitation, pulmonary rehabilitation, and chronic care management — combining AI-powered workflows with clinical teams. It serves hospitals and health systems, delivering end-to-end support for complex service lines.
Bioworld5 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Corwave5 shared keywordsCorWave is a medical device company developing heart-assist pumps designed as a physiological solution for patients with heart failure. It focuses on deep tech innovation in the cardiac care and implantable medical device space.
Cqmedical4 shared keywordsCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Corflow4 shared keywordsCorFlow develops the Controlled Flow Infusion (CoFI) System, a catheter-based device for cardiologists to diagnose microvascular obstruction in heart attack (STEMI) patients and deliver therapeutic agents directly into the vasculature during PCI procedures. The medical device integrates into existing catheterization workflows to detect MVO and support cardiac treatment.
Companies competing with Coraviemedical for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2022 | $275K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Coraviemedical do?
- CoraVie Medical is an early-stage company developing an implantable, ultrasound-based device for continuous, long-term blood pressure monitoring in people with hypertension. The system provides automatic measurement without cuffs or manual logging, aimed at giving physicians more reliable data for earlier intervention.
- Who founded Coraviemedical?
- Coraviemedical was founded by Aimee Garza.
- Who are Coraviemedical's investors?
- Coraviemedical's investors include Golden Seeds, GROOVE CAPITAL.